Spectrum Pharmaceuticals to present data on Ortataxel in breast cancer at major oncol

[News]

Spectrum Pharmaceuticals, Inc., will present Phase 2 data on ortataxel at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting being held May 30 to June 3, 2008 at the McCormick Place Convention Center in Chicago, Illinois.

More... (http://www.news-medical.net/?id=38426)